| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Martin Hoenigl | Q39596208 |
| Juergen Prattes | Q57145459 | ||
| P2093 | author name string | Matthias Egger | |
| Jeffrey D Jenks | |||
| P2860 | cites work | Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome | Q28264458 |
| Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia | Q28284944 | ||
| Invasive aspergillosis in the intensive care unit | Q28306909 | ||
| Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis | Q91867841 | ||
| Broad spectrum triazoles for invasive mould infections in adults: Which drug and when? | Q92002029 | ||
| Aspergillus colonization and antifungal immunity in cystic fibrosis patients | Q92002071 | ||
| Fungal Translocation: A Driving Force Behind the Occurrence of Non-AIDS Events? | Q92299837 | ||
| Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis | Q92553309 | ||
| Invasive aspergillosis in critically ill patients: An autopsy study | Q92610934 | ||
| Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression | Q93002541 | ||
| Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people | Q93068827 | ||
| Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology | Q93120379 | ||
| Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis | Q94844003 | ||
| Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection | Q95728018 | ||
| Aspergillus PCR: one step closer to standardization. | Q33769584 | ||
| Aspergillus colonization in patients with chronic obstructive pulmonary disease | Q33851401 | ||
| Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction | Q34052696 | ||
| Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens | Q34190354 | ||
| PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance | Q34298192 | ||
| Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America | Q34532546 | ||
| Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer | Q34688953 | ||
| Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients | Q35067116 | ||
| Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients | Q35575320 | ||
| Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity | Q35867884 | ||
| Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative. | Q35968600 | ||
| Analytical Comparison of In Vitro-Spiked Human Serum and Plasma for PCR-Based Detection of Aspergillus fumigatus DNA: a Study by the European Aspergillus PCR Initiative | Q35968684 | ||
| Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing | Q36094242 | ||
| Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections | Q36125981 | ||
| Evolution of antifungal-drug resistance: mechanisms and pathogen fitness | Q36161987 | ||
| Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations | Q36620825 | ||
| Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model | Q36734965 | ||
| Multicenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients. | Q36826645 | ||
| Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia | Q37099587 | ||
| Invasive aspergillosis in glucocorticoid-treated patients. | Q37226625 | ||
| (1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection? | Q37304283 | ||
| Mycobiome in the Lower Respiratory Tract - A Clinical Perspective. | Q37574834 | ||
| Aspergillus species intrinsically resistant to antifungal agents. | Q37775969 | ||
| Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial | Q38103680 | ||
| Azole resistance in Aspergillus fumigatus: a growing public health concern. | Q38152679 | ||
| Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. | Q38284458 | ||
| Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. | Q38983367 | ||
| Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test | Q38983372 | ||
| Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia. | Q39020600 | ||
| Fungi in the healthy human gastrointestinal tract | Q39295896 | ||
| Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. | Q39367515 | ||
| Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples | Q39990268 | ||
| Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis | Q40064394 | ||
| The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients. | Q40128466 | ||
| Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples | Q40208740 | ||
| Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. | Q40395042 | ||
| PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis. | Q40573555 | ||
| Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis | Q40984923 | ||
| Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis | Q41130252 | ||
| Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests | Q41289970 | ||
| Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. | Q41542809 | ||
| Intestinal fungi contribute to development of alcoholic liver disease. | Q41661762 | ||
| Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial | Q41692312 | ||
| Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis | Q41996921 | ||
| Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial | Q43107186 | ||
| Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. | Q43146785 | ||
| Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies | Q43839954 | ||
| Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. | Q44059632 | ||
| Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. | Q44222787 | ||
| Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies | Q45286729 | ||
| Don't throw your blood clots away: use of blood clot may improve sensitivity of PCR diagnosis in invasive aspergillosis | Q46135229 | ||
| Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit. | Q46320053 | ||
| Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus? | Q46616809 | ||
| Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum | Q47140701 | ||
| The Human Mucosal Mycobiome and Fungal Community Interactions | Q47711287 | ||
| Emergence of azole resistant Aspergillus fumigatus and One Health: Time to implement environmental stewardship | Q48115912 | ||
| Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. | Q49604618 | ||
| Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib | Q50044424 | ||
| Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips | Q50222798 | ||
| Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. | Q51047839 | ||
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. | Q51149137 | ||
| Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. | Q51175429 | ||
| Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. | Q51191991 | ||
| Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? | Q52592926 | ||
| The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. | Q53195957 | ||
| Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). | Q53477491 | ||
| Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples. | Q54217644 | ||
| Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. | Q54542822 | ||
| Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study | Q57173998 | ||
| Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
| Bronchoalveolar Lavage Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device Test for Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematological Malignancies | Q58560258 | ||
| Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUN gal infections Definitions in ICU patients ( FUNDICU ) project | Q64027938 | ||
| Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients | Q77228210 | ||
| The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study | Q80050239 | ||
| Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey | Q80052810 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases | Q84304099 | ||
| Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases | Q84839346 | ||
| Silent and prolonged Aspergillus DNAemia in oncohematological patients receiving antifungal prophylaxis: a new phenomenon with clinical implications | Q85095243 | ||
| Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability | Q88181101 | ||
| Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009-2013 | Q88541353 | ||
| Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples | Q89419439 | ||
| Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study | Q90273249 | ||
| Identification of Mycoses in Developing Countries | Q90382376 | ||
| Improving the rates of Aspergillus detection: an update on current diagnostic strategies | Q90578206 | ||
| Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage | Q90628627 | ||
| Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy | Q90895644 | ||
| Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium | Q91699004 | ||
| Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV | Q91736512 | ||
| Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis | Q91816417 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P577 | publication date | 2020-01-27 | |
| P1433 | published in | Journal of Fungi | Q27726983 |
| P1476 | title | Blood Aspergillus PCR: The Good, the Bad, and the Ugly | |
| P478 | volume | 6 |
Search more.